Startups

Ben Carson steps down from Vaccinogen board to focus on presidential campaign

CEO Andrew Tussing takes over as chairman as the new GOP contender hits the campaign trail.

Vaccinogen CEO Andrew Tussing. (Photo courtesy of Vaccinogen)

Ben Carson became a candidate for President this week. With the decision to seek the Republican nomination, the retired Johns Hopkins surgeon gave up a seat on the board of a Baltimore-based biotech company.

Ben Carson. (Via Twitter)

Ben Carson. (Via Twitter)


On Tuesday, Carson resigned as chairman of the board of Vaccinogen, a company working to make a vaccine that would keep colon cancer from recurring after surgery. The company relocated from Frederick to a new headquarters in Fells Point earlier this year.
“I continue to believe Vaccinogen’s patient-specific cancer vaccine platform truly has the potential to revolutionize cancer treatment and serve the greater good,” Carson said in a statement. “Despite my passion for this extremely important innovation, I now must focus my full attention on my campaign and serving the American people.”
Carson will be replaced on the board by Vaccinogen CEO Andrew L. Tussing, who will serve as chairman.

Companies: Vaccinogen

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

Our services Preferred partners The journalism fund
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

Interactive timeline: top moments from Baltimore’s challenging yet inspiring year in tech

Baltimore is setting a national standard for diversifying its economy

19 tech and entrepreneurship events to check out before the holidays

Tech lab space opening in new 4MLK building, thanks to $2M in public funds

Technically Media